Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianpi Fuzheng tea is a Traditional Chinese Medicine (TCM) hospital preparation developed by the Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, which is affiliated with the Shanghai University of Traditional Chinese Medicine. The formulation is specifically designed for the treatment and rehabilitation of patients following an ischemic stroke, particularly those presenting with TCM patterns of spleen deficiency and depletion of 'righteousness' (Qi). The tea is intended to strengthen the spleen, replenish vital energy, and support neurological recovery. It is typically administered as an oral medicinal tea or granule. As a multi-herb formula, it is thought to exert neuroprotective and anti-inflammatory effects, helping to alleviate post-stroke complications such as fatigue and functional impairment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jianpi fuzheng tea.